| 摘要 |
The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A', R 2 R 3, R 4 and R are as defined herein. The present invention also relates to compositions comprising at least one Heterocycle-Substituted Tetracyclic Compound, and methods of using the Heterocycle-Substituted Tetracyclic Compounds for treating or preventing HCV infection in a patient. |
| 申请人 |
MERCK SHARP AND DOHME CORP. |
发明人 |
YU, WENSHENG;TONG, LING;KOZLOWSKI, JOSEPH A.;SELYUTIN, OLEG;CHEN, LEI;KIM, JAE-HUN;SHA, DEYOU;RIZVI, RAZIA;SHANKAR, BANDARPALLE;HU, BIN;ZHONG, BIN;WANG, DAHAI;HAO, JINGLAI;WEI, WEI;JI, TAO;ZAN, SHUAI |
